Morningstar

Cardinal Health Inc CAH

Morningstar Rating
Unlock
Stock XNYS Rating as of
$235.80 +2.03 (0.87%)
View Full Chart
As of Delayed Price Pre-Open: $236.43 +0.62

Company Report

View Archive

Cardinal's Growth Momentum Looks Strong From Prescription Trends, Specialty Investments, and GLP-1s

Keonhee Kim

Cardinal Health is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With over $200 billion in annual US drug distribution sales in fiscal 2025, Cardinal supplies roughly one-fourth of the overall market. Its two closest competitors are Cencora and McKesson, and together they operate as a pharmaceutical wholesale and distribution oligopoly, supplying over 90% of the US market.

Read Full Report

Price vs Fair Value

View History
CAH is trading at a LOCK|GX^fB! premium.
Price
$235.80
Fair Value
LOCK|>c
Uncertainty
LOCK|Zz>>>
1-Star Price
LOCK|j.N?^
5-Star Price
LOCK|w.?
Economic Moat
LOCK|T%JK
Capital Allocation
LOCK|#W@j<c@

Bulls Say, Bears Say

Bulls

Cardinal Health distributes pharmaceutical products to nearly one third of the industry, leading to substantial negotiation leverage with generic drug manufacturers.

Bears

Reimbursement pressures on pharmacy and provider customers have led to an emphasis on cost containment, pressuring Cardinal Health’s profitability.

Show More

News

View All

Trading Information

Previous Close Price
$233.77
Day Range
$232.05–236.26
52-Week Range
$137.75–243.21
Bid/Ask
$230.00 / $238.06
Shares Outstanding
234.21M
Market Cap
$55.23B
Volume/Avg
557 / 2M

Key Statistics

Price/Earnings (Normalized)
22.74
Price/Sales
0.23
Dividend Yield (Trailing)
0.87%
Dividend Yield (Forward)
0.87%
Total Yield
2.69%

Company Profile

Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Mid Core
Total Number of Employees
57,700
Website
https://www.cardinalhealth.com

Competitors

Valuation

View More
Metric
CAH
MCK
COR
Price/Earnings (Normalized)
 22.7420.9118.57
Price/Book Value
 ——17.73
Price/Sales
 0.230.250.18
Price/Cash Flow
 16.3216.3516.06
Price/Earnings
CAH
MCK
COR

Financial Strength

Metric
CAH
MCK
COR
Quick Ratio
 0.420.480.48
Current Ratio
 0.910.850.95
Interest Coverage
 6.8425.388.18
Quick Ratio
CAH
MCK
COR

Profitability

Metric
CAH
MCK
COR
Return on Assets (Normalized)
 4.55%5.96%5.17%
Return on Equity (Normalized)
 ——201.23%
Return on Invested Capital (Normalized)
 45.01%60.93%38.43%
Return on Assets
CAH
MCK
COR

Medical Distribution Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
McKesson Corp
MCK
LOCK|Vy#@JL@LOCK|N!d?$94B
 Cencora Inc
COR
LOCK|p<JJ!^LOCK|>%Tk@$59B
 Sigma Healthcare Ltd
SIGGF
—LOCK|w?Br$23B
 Henry Schein Inc
HSIC
LOCK|p>t%CdCLOCK|>!gK$10B
 Shanghai Pharmaceuticals Holding Co Ltd ADR
SHPMY
—LOCK|$>Z$8B
 Sinopharm Group Co Ltd
SHTDF
—LOCK|>$y$7B
 Sinopharm Group Co Ltd ADR
SHTDY
—LOCK|Q$x$7B
 Medipal Holdings Corp ADR
MAHLY
—LOCK|G#$3B
 Medipal Holdings Corp
MEPDF
—LOCK|X@$3B

Sponsor Center